Paul Herendeen Insider Trading $BVF Bausch Health Companies Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul Herendeen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Herendeen. Paul Herendeen is EVP and CFO in Valeant Pharmaceuticals International, Inc. ($BVF) and EVP, Chief Financial Officer in Valeant Pharmaceuticals International, Inc. ($BVF) and Exec. V.P. and CFO in Warner Chilcott plc ($WCRX) and Exec. V.P. and CFO in Zoetis Inc. ($ZTS).
Paul Herendeen in Bausch Health Companies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul Herendeen: EVP and CFO, EVP, Chief Financial Officer
Holdings: 395,619 shares
Latest Transaction: Mar 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Paul Herendeen in Bausch Health Companies Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BVF, WCRX, ZTS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Option Exercise | M | 0.00 | 49,324 | 0 | 0 | |
| Mar 10 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 32.97 | 59,519 | 1,962,341 | 386,618 | 446.1 K to 386.6 K (-13.34 %) |
| Mar 10 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Grant | A | 0.00 | 50,518 | 0 | 446,137 | 395.6 K to 446.1 K (+12.77 %) |
| Mar 10 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Buy | M | 0.00 | 49,324 | 0 | 395,619 | 346.3 K to 395.6 K (+14.24 %) |
| Mar 05 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Option Exercise | A | 32.56 | 91,684 | 2,985,231 | 91,684 | |
| Mar 05 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Grant | A | 0.00 | 63,439 | 0 | 346,295 | 282.9 K to 346.3 K (+22.43 %) |
| Sep 16 2020 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 15.91 | 1,642 | 26,124 | 298,611 | 300.3 K to 298.6 K (-0.55 %) |
| Mar 11 2020 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 20.96 | 9,328 | 195,515 | 300,253 | 309.6 K to 300.3 K (-3.01 %) |
| Feb 28 2020 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Option Exercise | A | 24.77 | 159,192 | 3,943,186 | 159,192 | |
| Feb 28 2020 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Grant | A | 0.00 | 63,030 | 0 | 316,748 | 253.7 K to 316.7 K (+24.84 %) |
| Sep 18 2019 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 23.24 | 1,642 | 38,160 | 253,718 | 255.4 K to 253.7 K (-0.64 %) |
| Aug 27 2019 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 22.40 | 24,625 | 551,600 | 255,360 | 280 K to 255.4 K (-8.80 %) |
| Mar 12 2019 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 23.56 | 9,796 | 230,794 | 279,985 | 289.8 K to 280 K (-3.38 %) |
| Mar 01 2019 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Option Exercise | A | 23.16 | 124,002 | 2,871,886 | 124,002 | |
| Mar 01 2019 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Grant | A | 0.00 | 62,915 | 0 | 289,781 | 226.9 K to 289.8 K (+27.73 %) |
| Sep 17 2018 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Grant | A | 0.00 | 10,000 | 0 | 226,866 | 216.9 K to 226.9 K (+4.61 %) |
| Sep 17 2018 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Buy | P | 22.61 | 10,000 | 226,100 | 216,866 | 206.9 K to 216.9 K (+4.83 %) |
| Aug 27 2018 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 22.37 | 24,626 | 550,884 | 206,866 | 231.5 K to 206.9 K (-10.64 %) |
| Mar 13 2018 | BVF | Valeant Pharmaceut ... | Herendeen Paul | EVP and CFO | Buy | P | 16.10 | 15,000 | 241,470 | 231,492 | 216.5 K to 231.5 K (+6.93 %) |
| Mar 09 2018 | BVF | Valeant Pharmaceut ... | Herendeen Paul | EVP and CFO | Option Exercise | A | 0.00 | 79,556 | 0 | 79,556 | |
| Mar 09 2018 | BVF | Valeant Pharmaceut ... | Herendeen Paul | EVP and CFO | Option Exercise | A | 15.32 | 177,482 | 2,719,024 | 177,482 | |
| Mar 09 2018 | BVF | Valeant Pharmaceut ... | Herendeen Paul | EVP and CFO | Grant | A | 0.00 | 59,667 | 0 | 216,492 | 156.8 K to 216.5 K (+38.05 %) |
| Aug 25 2017 | BVF | Valeant Pharmaceut ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 14.14 | 17,175 | 242,855 | 156,825 | 174 K to 156.8 K (-9.87 %) |
| Mar 16 2017 | BVF | Valeant Pharmaceut ... | Herendeen Paul | EVP and CFO | Buy | P | 10.72 | 24,000 | 257,280 | 174,000 | 150 K to 174 K (+16.00 %) |
| Aug 24 2016 | BVF | Valeant Pharmaceut ... | Herendeen Paul | EVP, Chief Financia ... | Option Exercise | A | 28.74 | 1,000,000 | 28,740,000 | 1,000,000 | |
| Aug 24 2016 | BVF | Valeant Pharmaceut ... | Herendeen Paul | EVP, Chief Financia ... | Grant | A | 0.00 | 150,000 | 0 | 150,000 | 0 to 150 K |
Page: 1